Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 383608, 8 pages
http://dx.doi.org/10.1155/2012/383608
Research Article

Luteolin Suppresses Inflammatory Mediator Expression by Blocking the Akt/NFκB Pathway in Acute Lung Injury Induced by Lipopolysaccharide in Mice

1Department of Pharmacology, School of Medicine, Chung Shan Medical University, No. 110, Sec.1, Jianguo N. Road, Taichung 40201, Taiwan
2Department of Pharmacy, Chung Shan Medical University Hospital, Taichung, Taiwan
3Department of Neurology, Show Chwan Memorial Hospital, Changhua, Taiwan
4Graduate Institute of Life Sciences, National Chung Hsing University, Taichung, Taiwan
5Department of Anatomy, School of Medicine, Chung Shan Medical University, No. 110, Sec.1, Jianguo N. Road, Taichung 40201, Taiwan

Received 20 July 2011; Revised 9 September 2011; Accepted 9 September 2011

Academic Editor: Bashar Saad

Copyright © 2012 Yi-Ching Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Hasday, R. Bascom, J. J. Costa, T. Fitzgerald, and W. Dubin, “Bacterial endotoxin is an active component of cigarette smoke,” Chest, vol. 115, no. 3, pp. 829–835, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Reutershan, A. Basit, E. V. Galkina, and K. Ley, “Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 289, no. 5, pp. L807–L815, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Bhatia and S. Moochhala, “Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome,” Journal of Pathology, vol. 202, no. 2, pp. 145–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Zhou, J. Kozlowski, and D. P. Schuster, “Physiologic, biochemical, and imaging characterization of acute lung injury in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 3, pp. 344–351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. P. P. Tak and G. S. Firestein, “NF-κB: a key role in inflammatory diseases,” Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at Google Scholar · View at Scopus
  6. Z. He, Y. Zhu, and H. Jiang, “Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study,” Respiratory Research, vol. 10, p. 126, 2009. View at Google Scholar · View at Scopus
  7. M. López-Lázaro, “Distribution and biological activities of the flavonoid luteolin,” Mini-Reviews in Medicinal Chemistry, vol. 9, no. 1, pp. 31–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. G. K. Harris, Y. Qian, S. S. Leonard, D. C. Sbarra, and X. Shi, “Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells,” Journal of Nutrition, vol. 136, no. 6, pp. 1517–1521, 2006. View at Google Scholar · View at Scopus
  9. H. W. Lu, K. Sugahara, Y. Sagara et al., “Effect of three flavonoids, 5,7,3',4'-tetrahydroxy-3-methoxy flavone, luteolin, and quercetin, on the stimulus-induced superoxide generation and tyrosyl phosphorylation of proteins in human neutrophil,” Archives of Biochemistry and Biophysics, vol. 393, no. 1, pp. 73–77, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kotanidou, A. Xagorari, E. Bagli et al., “Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 6, pp. 818–823, 2002. View at Google Scholar · View at Scopus
  11. J. P. Lee, Y. C. Li, H. Y. Chen et al., “Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils,” Acta Pharmacologica Sinica, vol. 31, no. 7, pp. 831–838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. H. Pan, S. Y. Lin, Y. C. Ou et al., “Stearic acid attenuates cholestasis-induced liver injury,” Biochemical and Biophysical Research Communications, vol. 391, no. 3, pp. 1537–1542, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Reutershan, M. A. Morris, T. L. Burcin et al., “Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 695–702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Shang, X. Li, P. V. Prasad et al., “Erythropoietin attenuates lung injury in lipopolysaccharide treated rats1,” Journal of Surgical Research, vol. 155, no. 1, pp. 104–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Fukunaga, P. Kohli, C. Bonnans, L. E. Fredenburgh, and B. D. Levy, “Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury,” Journal of Immunology, vol. 174, no. 8, pp. 5033–5039, 2005. View at Google Scholar · View at Scopus
  16. J. Fan, R. D. Ye, and A. B. Malik, “Transcriptional mechanisms of acute lung injury,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 281, no. 5, pp. L1037–L1050, 2001. View at Google Scholar · View at Scopus
  17. M. S. Hayden, A. P. West, and S. Ghosh, “NF-κB and the immune response,” Oncogene, vol. 25, no. 51, pp. 6758–6780, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. P. Wymann, M. Zvelebil, and M. Laffargue, “Phosphoinositide 3-kinase signalling—which way to target?” Trends in Pharmacological Sciences, vol. 24, no. 7, pp. 366–376, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Chen, C. Bai, and X. Wang, “The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine,” Expert Review of Respiratory Medicine, vol. 4, no. 6, pp. 773–783, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. E. Driscoll, D. L. Costa, G. Hatch et al., “Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations,” Toxicological Sciences, vol. 55, no. 1, pp. 24–35, 2000. View at Google Scholar · View at Scopus
  21. E. L. Burnham, “Circulating progenitors in lung injury: a novel therapy for acute respiratory distress syndrome?” Anesthesiology, vol. 108, no. 3, pp. 354–356, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. O. A. Khair, R. J. Davies, and J. L. Devalia, “Bacterial-induced release of inflammatory mediators by bronchial epithelial cells,” European Respiratory Journal, vol. 9, no. 9, pp. 1913–1922, 1996. View at Google Scholar · View at Scopus
  23. N. Wang, K. L. Gates, H. Trejo et al., “Elevated CO2 selectively inhibits interleukin-6 and tumor necrosis factor expression and decreases phagocytosis in the macrophage,” Journal of the Federation of American Societies for Experimental Biology, vol. 24, no. 7, pp. 2178–2190, 2010. View at Google Scholar
  24. E. Abraham, “Neutrophils and acute lung injury,” Critical Care Medicine, vol. 31, supplement, no. 4, pp. S195–S199, 2003. View at Google Scholar · View at Scopus
  25. C. Y. Chen, W. H. Peng, L. C. Wu, C. C. Wu, and S. L. Hsu, “Luteolin ameliorates experimental lung fibrosis both in vivo and in vitro: implications for therapy of lung fibrosis,” Journal of Agricultural and Food Chemistry, vol. 58, no. 22, pp. 11653–11661, 2010. View at Google Scholar
  26. A. Giebelen, D. J. van Westerloo, G. J. LaRosa, A. F. de Vos, and T. van der Poll, “Local stimulation of α7 cholinergic receptors inhibits LPS-induced TNF-α release in the mouse lung,” Shock, vol. 28, no. 6, pp. 700–703, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. C. B. Marsh and M. D. Wewers, “The response to gram-negative pathogenesis of sepsis. Factors that modulate bacterial infection,” Clinics in Chest Medicine, vol. 17, no. 2, pp. 183–197, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Agouridakis, D. Kyriakou, M. G. Alexandrakis et al., “The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome,” Respiratory Research, vol. 3, pp. 25–33, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Y. Chen, W. H. Peng, K. D. Tsai, and S. L. Hsu, “Luteolin suppresses inflammation-associated gene expression by blocking NF-κB and AP-1 activation pathway in mouse alveolar macrophages,” Life Sciences, vol. 81, no. 23-24, pp. 1602–1614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. K. S. Farley, L. F. Wang, H. M. Razavi et al., “Effects of macrophage inducible nitric oxide synthase in murine septic lung injury,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 290, no. 6, pp. L1164–L1172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. C. L. Speyer, T. A. Neff, R. L. Warner et al., “Regulatory effects of iNOS on acute lung inflammatory responses in mice,” American Journal of Pathology, vol. 163, no. 6, pp. 2319–2328, 2003. View at Google Scholar · View at Scopus
  32. P. A. Baeuerle and T. Henkel, “Function and activation of NF-κB in the immune system,” Annual Review of Immunology, vol. 12, pp. 141–179, 1994. View at Google Scholar · View at Scopus
  33. T. R. Martin and C. W. Frevert, “Innate immunity in the lungs,” Proceedings of the American Thoracic Society, vol. 2, no. 5, pp. 403–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. K. M. Ardeshna, A. R. Pizzey, S. Devereux, and A. Khwaja, “The PI3 kinase, p38 SAP kinase, and NF-κb signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells,” Blood, vol. 96, no. 3, pp. 1039–1046, 2000. View at Google Scholar · View at Scopus